Oestrogen deficiency modulates particle-induced osteolysis

Arthritis Research and Therapy

Volumn 13, Issue 3, 2011, Pages

  Nich, Christophe ^a   Langlois, Jean ^a   Marchadier, Arnaud ^b,c   Vidal, Catherine ^c   Cohen Solal, Martine ^d   Petite, Hervé ^a   Hamadouche, Moussa ^a  

^a Paris university   (France)

^b Useful Progress   (France)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ESTRADIOL; ESTROGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; POLYETHYLENE; TARTARIC ACID; TUMOR NECROSIS FACTOR ALPHA; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALVARIA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN DEFICIENCY; FEMALE; GENE EXPRESSION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SUPPLEMENTATION; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GENETICS; METABOLISM; ORGAN CULTURE TECHNIQUE; OSTEOPOROSIS; PATHOLOGY; PHYSIOLOGY; RADIOGRAPHY; SKULL;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GENE EXPRESSION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; OSTEOLYSIS; OSTEOPOROSIS; OSTEOPROTEGERIN; OVARIECTOMY; POLYETHYLENE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SKULL; TUMOR NECROSIS FACTOR-ALPHA; X-RAY MICROTOMOGRAPHY;

EID: 79959344681     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3381     Document Type: Article

References (46)

1. Willert HG, Bertram H, Buchhorn GH. Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res 1990, 258:95-107.
2. Schwarz EM, O'Keefe RJ, Looney RJ. Bone implant interface, osteolysis and potential therapies. J Musculoskelet Neuronal Interact 2004, 4:390-392.
3. Kobayashi S, Takaoka K, Saito N, Hisa K. Factors affecting aseptic failure of fixation after primary Charnley total hip arthroplasty. Multivariate survival analysis. J Bone Joint Surg Am 1997, 79:1618-1627.
4. von Knoch M, Jewison DE, Sibonga JD, Turner RT, Morrey BF, Loer F, Berry DJ, Scully SP. Decrease in particle-induced osteolysis in obese (ob/ob) mice. Biomaterials 2004, 25:4675-4681. 10.1016/j.biomaterials.2004.02.069, 15120513.
5. Zhang C, Tang T, Ren W, Zhang X, Dai K. Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res 2008, 57:211-215. 10.1007/s00011-007-7040-3, 18465085.
6. Nich C, Marchadier A, Sedel L, Petite H, Vidal C, Hamadouche M. Decrease in particle-induced osteolysis in ovariectomized mice. J Orthop Res 2010, 28:178-183.
7. Ishiguro N, Kojima T, Ito T, Saga S, Anma H, Kurokouchi K, Iwahori Y, Iwase T, Iwata H. Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res 1997, 35:399-406. 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A, 9138074.
8. Green TR, Fisher J, Matthews JB, Stone MH, Ingham E. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res 2000, 53:490-497. 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7, 10984696.
9. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNFalpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004, 15:49-60. 10.1016/j.cytogfr.2003.10.005, 14746813.
10. Wronski TJ, Dann LM, Scott KS, Cintrón M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 1989, 45:360-366. 10.1007/BF02556007, 2509027.
11. Passeri G, Girasole G, Jilka RL, Manolagas SC. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 1993, 133:822-828. 10.1210/en.133.2.822, 8393776.
12. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 1999, 13:819-828. 10.1210/me.13.6.819, 10379881.
13. Müller R, van Campenhout H, van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, Rüegsegger P. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 1998, 23:59-66. 10.1016/S8756-3282(98)00068-4, 9662131.
14. van den Brink HR, van Everdingen AA, van Wijk MJ, Jacobs JW, Bijlsma JW. Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis 1993, 52:862-865. 10.1136/ard.52.12.862, 1005216, 8311536.
15. Hall GM, Daniels M, Huskisson EC, Spector TD. A randomized controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 1994, 53:112-116. 10.1136/ard.53.2.112, 1005262, 8129455.
16. D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H. Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis Res Ther 2003, 5:202-209. 10.1186/ar788, 165069, 12823851.
17. Yoneda T, Ishimaru N, Arakaki R, Kobayashi M, Izawa T, Moriyama K, Hayashi Y. Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Endocrinology 2004, 145:2384-2391. 10.1210/en.2003-1536, 14726437.
18. Subramanian S, Tovey M, Afentoulis M, Krogstad A, Vandenbark AA, Offner H. Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol 2005, 115:162-172. 10.1016/j.clim.2005.01.006, 15885639.
19. da Silva JA, Willoughby DA. The influence of sex in arthritis: is cartilage an overlooked factor?. J Rheumatol 1994, 21:791-796.
20. Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 1996, 271:28890-28897. 10.1074/jbc.271.46.28890, 8910536.
21. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, Mc Cabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402:304-309. 10.1038/46303, 10580503.
22. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, Mc Cabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000, 97:1566-1571. 10.1073/pnas.97.4.1566, 26475, 10677500.
23. Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab 2000, 18:344-349. 10.1007/s007740070007, 11052468.
24. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S. Estrogen prevents bone loss via oestrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007, 130:811-823. 10.1016/j.cell.2007.07.025, 17803905.
25. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001, 16:338-347. 10.1359/jbmr.2001.16.2.338, 11204434.
26. Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 2001, 276:563-568.
27. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995, 136:3054-3061. 10.1210/en.136.7.3054, 7789332.
28. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which oestrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 2001, 98:13960-13965. 10.1073/pnas.251534698, 61149, 11717453.
29. Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM. Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone 2007, 40:1276-1283. 10.1016/j.bone.2006.12.053, 1930165, 17236833.
30. Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006, 85:596-607. 10.1177/154405910608500704, 16798858.
31. Lorenzo J. Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest 2000, 106:749-752. 10.1172/JCI11089, 381401, 10995785.
32. Hernigou P, Intrator L, Bahrami T, Bensussan A, Farcet JP. Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res 1999, 366:147-154.
33. Tanaka R, Yasunaga Y, Hisatome T, Yamasaki T, Iwamori H, Ochi M. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty 2005, 20:1049-1054. 10.1016/j.arth.2005.03.034, 16376262.
34. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 2000, 106:1229-1237. 10.1172/JCI11066, 381439, 11086024.
35. Weitzmann MN, Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev 2005, 208:154-168. 10.1111/j.0105-2896.2005.00324.x, 16313347.
36. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996, 11:1043-1051.
37. Sato T, Watanabe K, Masuhara M, Hada N, Hakeda Y. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. J Bone Miner Metab 2007, 25:19-27.
38. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, Fu YX. Adaptive immune cells temper initial innate responses. Nat Med 2007, 13:1248-1252. 10.1038/nm1633, 2435248, 17891146.
39. Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009, 460:269-273. 10.1038/nature08100, 19494813.
40. Everts V, de Vries TJ, Helfrich MH. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta 2009, 1792:757-765.
41. de Souza Faloni AP, Schoenmaker T, Azari A, Katchburian E, Cerri PS, de Vries TJ, Everts V. Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int 2011, 88:63-74. 10.1007/s00223-010-9418-4, 3021190, 20862464.
42. Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res 2006, 21:1399-1408. 10.1359/jbmr.060614, 16939398.
43. Perez-Amodio S, Jansen DC, Schoenmaker T, Vogels IM, Reinheckel T, Hayman AR, Cox TM, Saftig P, Beertsen W, Everts V. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcif Tissue Int 2006, 79:245-254. 10.1007/s00223-005-0289-z, 17033726.
44. van de Bos T, Speijer D, Bank RA, Bromme D, Everts V. Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: Special emphasis on collagen. Bone 2008, 43:459-468. 10.1016/j.bone.2008.05.009, 18583211.
45. Libouban H, Moreau MF, Baslé MF, Bataille R, Chappard D. Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone 2003, 33:283-292. 10.1016/S8756-3282(03)00196-0, 13678768.
46. Takata S, Takao S, Yoshida S, Hayashi F, Yasui N. Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with pariétal thinning of skull. J Med Invest 2008, 55:297-302. 10.2152/jmi.55.297, 18797147.